MetLife
1,084 hedge funds and large institutions have $40.9B invested in MetLife in 2017 Q4 according to their latest regulatory filings, with 160 funds opening new positions, 370 increasing their positions, 409 reducing their positions, and 54 closing their positions.
196% more first-time investments, than exits
New positions opened: 160 | Existing positions closed: 54
10% more funds holding
Funds holding: 985 → 1,084 (+99)
0.5% more ownership
Funds ownership: 76.42% → 76.92% (+0.5%)
3% less capital invested
Capital invested by funds: $42.1B → $40.9B (-$1.19B)
4% less call options, than puts
Call options by funds: $709M | Put options by funds: $735M
10% less repeat investments, than reductions
Existing positions increased: 370 | Existing positions reduced: 409
46% less funds holding in top 10
Funds holding in top 10: 24 → 13 (-11)
Top Buyers
| 1 |
SSM
Sound Shore Management
Greenwich,
Connecticut
|
+$187M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$167M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$165M |
| 4 |
HSBC Holdings
London,
United Kingdom
|
+$123M |
| 5 |
BlackRock
New York
|
+$57.8M |
Top Sellers
MET Hedge Fund Activity: Q4 2017 in Review
1,084 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in MetLife (MET) for Q4 2017, worth a combined $40.9B — down 2.8% from $42.1B a quarter earlier.
Buyers outnumbered sellers: 160 funds opened new MET positions and 54 closed out — a net gain of 106 holders — while 370 added to existing stakes and 409 trimmed.
The largest buyer was Sound Shore Management, opening a new position worth an estimated $187M. The largest seller was T. Rowe Price Associates, cutting an estimated $249M.
- 1,084 institutional investors held MetLife (MET) as of Q4 2017, up from 985 in Q3 2017.
- Funds reported $40.9B of MetLife stock for Q4 2017, down 2.8% quarter-over-quarter.
- 160 funds opened new MetLife positions in Q4 2017 and 54 closed out, a net change of +106 holders.
- The largest MetLife buyer in Q4 2017 was Sound Shore Management, an estimated $187M added.
- The largest MetLife seller in Q4 2017 was T. Rowe Price Associates, an estimated $249M sold.
Based on aggregated 13F filings for Q4 2017.